Dr. Marcelo Samsa holds a PhD in Molecular Virology and completed postdoctoral training at Novartis Vaccines and Diagnostics in Massachusetts. He currently leads the Laboratory of Applied RNA Technology (LART), a pioneering hub in Puerto Rico focused on advancing mRNA and self-amplifying RNA platforms for next-generation vaccines and therapeutics. His team specializes in molecular design, synthesis, formulation, and both in vitro and in vivo studies—bringing deep RNA innovation to life with tangible impact.

With extensive experience in mRNA technology, Dr. Samsa combines scientific rigor with entrepreneurial vision. He has a proven track record of translating early-stage RNA technologies into scalable platforms that bridge academic discovery and practical applications. His leadership sets BioVergence apart in the rapidly evolving landscape of RNA-based medicine and personalized health.